Inicio>>Signaling Pathways>> PROTAC>>PROTAC BET degrader-2

PROTAC BET degrader-2

Catalog No.GC32980

PROTAC BET degradador-2 es un PROTAC conectado por ligandos para Cereblon y BET con un valor IC50 de 9,6 nM en la inhibiciÓn del crecimiento celular en las células RS4;11 y capaz de lograr la regresiÓn tumoral.

Products are for research use only. Not for human use. We do not sell to patients.

PROTAC BET degrader-2 Chemical Structure

Cas No.: 2093388-33-9

Tamaño Precio Disponibilidad Cantidad
10mM (in 1mL DMSO)
662,00 $
Disponible
5mg
506,00 $
Disponible
10mg
782,00 $
Disponible
25mg
1.701,00 $
Disponible

Tel:(909) 407-4943 Email: sales@glpbio.com

Reseñas de cliente

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

PROTAC BET degrader-2 is a highly potent degrader of Bromodomain and Extra-Terminal (BET) proteins with an IC50 value of 9.6 nM in cell growth inhibition in the RS4;11 cells and capable of achieving tumor regression.

PROTAC BET degrader-2 (compound 25) is a highly potent degrader of Bromodomain and Extra-Terminal (BET) proteins with an IC50 value of 9.6 nM in cell growth inhibition in the RS4;11 cells and capable of achieving tumor regression[1].

[1]. Zhou B, et al. Discovery of a Small-Molecule Degrader of Bromodomain and Extra-Terminal (BET) Proteins with Picomolar Cellular Potencies and Capable of Achieving Tumor Regression. J Med Chem. 2018 Jan 25;61(2):462-481.

Reseñas

Review for PROTAC BET degrader-2

Average Rating: 5 ★★★★★ (Based on Reviews and 13 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for PROTAC BET degrader-2

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.